Week In Review: CFDA Begins Reform Of China Drug Approval Process
November 21, 2015 at 14:32 PM EST
Over the next five years, China's spending on medicines will grow at a 6-9% CAGR, with a total drug spend of $150-$180 billion in 2020, according to a forecast released by healthcare consultancy IMS.
